Zynex Inc. (ZYXI)
2.45
-0.12 (-4.67%)
At close: Mar 21, 2025, 3:59 PM
-4.67% (1D)
| Bid | 2.41 |
| Market Cap | 78.19M |
| Revenue (ttm) | 192.52M |
| Net Income (ttm) | 3M |
| EPS (ttm) | 0.09 |
| PE Ratio (ttm) | 27.22 |
| Forward PE | 16.93 |
| Analyst | Hold |
| Ask | 2.68 |
| Volume | 287,559 |
| Avg. Volume (20D) | 193,786 |
| Open | 2.54 |
| Previous Close | 2.57 |
| Day's Range | 2.41 - 2.58 |
| 52-Week Range | 2.41 - 13.04 |
| Beta | 0.81 |
About ZYXI
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by fiel...
Industry Medical - Distribution
Sector Healthcare
IPO Date Feb 25, 2004
Employees 1,000
Stock Exchange NASDAQ
Ticker Symbol ZYXI
Website https://www.zynex.com
Analyst Forecast
According to 3 analyst ratings, the average rating for ZYXI stock is "Hold." The 12-month stock price forecast is $10.25, which is an increase of 318.37% from the latest price.
Stock ForecastsEarnings Surprise
Zynex has released their quartely earnings
on Mar 11, 2025:
Next Earnings Release
Zynex Inc. is scheduled to release its earnings on Apr 29, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-51.29%
Zynex shares are trading lower after HC Wainwright...
Unlock content with
Pro Subscription
1 week ago
-2.37%
Zynex shares are trading lower following worse-than-expected Q4 financial results.
